Phase II trial of vinorelbine in metastatic squamous cell esophageal carcinoma

Journal of Clinical Oncology

Volumn 14, Issue 1, 1996, Pages 164-170

  Conroy, T ^a   Etienne, P L ^a   Adenis, A ^a   Wagener, D J ^a   Paillot, B ^a   Francois E ^a   Bedenne, L ^a   Jacob, J H ^a   Seitz, J F ^a   Bleiberg, H ^a   Van Pottelsberghe, C ^a   Van Glabbeke, M ^a   Delgado, F M ^a   Merle, S ^a   Wils, J ^a  

^a CENTRE ALEXIS VAUTRIN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CISPLATIN; ETOPOSIDE; FLUOROURACIL; NAVELBINE;

ALLERGIC REACTION; ALOPECIA; ARTICLE; ASTHENIA; CARDIOTOXICITY; CLINICAL ARTICLE; CLINICAL TRIAL; CONSTIPATION; DOSE RESPONSE; DRUG FEVER; DRUG TOLERABILITY; ESOPHAGUS CARCINOMA; FEMALE; GASTROINTESTINAL TOXICITY; GRANULOCYTOPENIA; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LIVER TOXICITY; LUNG TOXICITY; MALE; METASTASIS; MUCOSA INFLAMMATION; NEPHROTOXICITY; NEUROTOXICITY; PERIPHERAL NEUROPATHY; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL;

EID: 9044224771     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1996.14.1.164     Document Type: Article

References (36)

1. Parkin DM, Pisani P, Ferlay J: Estimates of the worldwide incidence of eighteen major cancers in 1985. Int J Cancer 54:594-606, 1993
2. Wingo PA, Tong T, Bolden S: Cancer statistics, 1995. CA-A 45:8-30, 1995
3. La Vecchia C, Lucchini F, Negri E, et al: Trends of cancer mortality in Europe, 1955-1989: I, digestive sites. Eur J Cancer 28:132-235, 1992
4. Calament G, Cauvin JM, Robaszkiewicz M, et al: Esophageal squamous cell carcinoma in the French county of Finistère between 1984 and 1988: Treatment and survival analysis in 716 cases. Gastroenterol Clin Biol 17:9-16, 1993
5. Herskovic A, Martz K, Al-Sarraf M, et al: Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med 326:1593-1598, 1992
6. Kavanagh B, Anscher M, Leopold K, et al: Patterns of failure following combined modality therapy for esophageal cancer, 1984-1990. Int J Radiat Oncol Biol Phys 24:633-642, 1992
7. Bosch A, Frias Z, Caldwell WL, et al: Autopsy findings in carcinoma of the esophagus. Acta Radiol Oncol 18:103-112, 1979
8. Mandard AM, Chasle J, Marnay J, et al: Autopsy findings in 111 cases of esophageal cancer. Cancer 48:329-335, 1981
9. Anderson LL, Lad TE: Autopsy findings in squamous-cell carcinoma of the esophagus. Cancer 50:1587-1590, 1982
10. Ajani JA: Contributions of chemotherapy in the treatment of carcinoma of the esophagus: Results and commentary. Semin Oncol 21:474-482, 1994
11. Ajani JA, Ilson DH, Daugherty K, et al: Activity of Taxol in patients with squamous cell carcinoma and adenocarcinoma of the esophagus. J Natl Cancer Inst 86:1086-1091, 1994
12. Davis S, Shanmugathasa M, Kessler W: Cis-dichlorodiammineplatinum (II) in the treatment of esophageal carcinoma. Cancer Treat Rep 64:709-711, 1980
13. Engstrom PF, Lavin PT, Klassen DJ: Phase II evaluation of mitomycin and cisplatin in advanced esophageal carcinoma. Cancer Treat Rep 67:713-715, 1983
14. Panettiere FJ, Leichman LP, Tilchen EJ, et al: Chemotherapy for advanced epidermoid carcinoma of the esophagus with single-agent cisplatin: Final report on a Southwest Oncology Group study. Cancer Treat Rep 68:1023-1024, 1984
15. Ravry MJR, Moore MR, Omura GA, et al: Phase II evaluation of cisplatin in squamous carcinoma of the esophagus. A Southeastern Cancer Study Group trial. Cancer Treat Rep 69:1457-1458, 1985
16. Bleiberg M, Jacob JH, Bedenne L, et al: Randomized phase II trial of 5-fluorouracil (5FU) and cisplatin (DDP) versus DDP alone in advanced oesophageal cancer. Proc Am Soc Clin Oncol 10:145, 1991 (abstr 447)
17. Potier P: The synthesis of Navelbine prototype of a new series of vinblastine derivatives. Semin Oncol 16:2-4, 1989, suppl 4
18. Mathé G, Reizenstein P: Phase I pharmacologic study of a new vinca-alkaloid: Navelbine. Cancer Lett 27:285-293, 1985
19. Fumoleau P, Delgado FM, Delozier T, et al: Phase II trial of weekly intravenous vinorelbine in first-line advanced breast cancer chemotherapy. J Clin Oncol 11:1245-1252, 1993
20. Le Chevalier T, Brisgand D, Douillard JY, et al: Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small-cell lung cancer: Results of a European multicenter trial including 612 patients. J Clin Oncol 12:360-367, 1994
21. Goa KL, Faulds D: Vinorelbine. A review of its pharmacological properties and clinical use in cancer chemotherapy. Drugs Aging 5:200-234, 1994
22. Miller AB, Hoogstraten B, Staquet M, et al: Reporting results of cancer treatment. Cancer 47:207-214, 1981
23. Gehan EA: The determination of the number of patients required in a preliminary and a follow-up trial of a new chemotherapy agent. J Chronic Dis 13:346-353, 1961
24. Coia LR, Soffen EM, Schultheiss TE, et al: Swallowing function in patients with esophageal cancer treatment with concurrent radiation and chemotherapy. Cancer 71:281-286, 1993 (suppl 1)
25. Coia LR: The use of mitomycin in esophageal cancer. Oncology 50:53-62, 1993
26. Kelsen DP, Bains MS, Cvitkovic E, et al: Vindesine in the treatment of esophageal carcinoma: A phase II study. Cancer Treat Rep 63:2019-2021, 1979
27. Bedikian AY, Valdivieso M, Bodey GP, et al: Phase II evaluation of vindesine in the treatment of colorectal and esophageal tumors. Cancer Chemother Pharmacol 2:263-266, 1979
28. Bezwoda WR, Derman DP, Weaving A, et al: Treatment of esophageal cancer with vindesine: An open trial. Cancer Treat Rep 68:783-785, 1984
29. Japanese Esophageal Oncology Group: A phase II study of vindesine in the treatment of esophageal carcinoma. Jpn J Clin Oncol 19:380-383, 1989
30. Conroy T: Measurement of the primary esophageal tumor, in Wils J, Bleiberg H (eds): Diagnosis and Treatment of Gastrointestinal Tract Cancer. Brentwood, United Kingdom, Multiscience Publishing, 1993, pp 28-30
31. Soto Parra H, Bidoli P, Santoro A, et al: A phase II study with vinorelbine (VNB): an active new agent in squamous cell carcinoma of the esophagus (SCCE). Ann Oncol 5:77-78, 1994 (suppl 8, abstr P 386)
32. Gebbia V, Testa A, Valenza R, et al: A pilot study of vinorelbine on a weekly schedule in recurrent and/or metastatic squamous cell carcinoma of the head and neck. Eur J Cancer 29A: 1358-1359, 1993
33. Testolin A, Recher G, Pozza F, et al: Vinorelbine (VNB) in pre-treated advanced head and neck squamous cell carcinoma (AH & NSCC): A phase II study. Proc Am Soc Clin Oncol 13:289, 1994 (abstr 938)
34. Kelsen D, Hilaris B, Coonley C, et al: Cisplatin, vindesine, and bleomycin chemotherapy of local-regional and advanced esophageal carcinoma. Am J Med 75:645-652, 1983
35. Ezdinli EZ, Gelber R, Desai DV, et al: Chemotherapy of advanced esophageal carcinoma: Eastern Cooperative Oncology Group experience. Cancer 46:2149-2153, 1980
36. Stahl M, Wilke H, Meyer HJ, et al: 5-Fluorouracil, folinic acid, etoposide and cisplatin chemotherapy for locally advanced or metastatic carcinoma of the oesophagus. Eur J Cancer 30A:325-328, 1994